Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: Application to a clinical study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 2, 2008, Pages 349-355

  Zhu, Yu Bing ^a   Zhang, Qian ^b   Zou, Jian Jun ^a   Yu, Cui Xia ^a   Xiao, Da Wei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

4 Hydroxytamoxifen; Bioavailability; N Desmethyltamoxifen; Tamoxifen; Triphenylethylene fluorescence

Indexed keywords

1,1,2 TRIPHENYLETHYLENE DERIVATIVE; 4 HYDROXYTAMOXIFEN; DRUG METABOLITE; METHANOL; MEXILETINE; NORTAMOXIFEN; TAMOXIFEN; TRIETHYLAMINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYCLIZATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; ULTRAVIOLET IRRADIATION;

ANTINEOPLASTIC AGENTS, HORMONAL; BIOLOGICAL AVAILABILITY; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; TAMOXIFEN;

EID: 37749052783     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.10.012     Document Type: Article

References (30)

1. Winer E.P., Hudis C., Burstein H.J., Chlebowski R.T., Ingle J.N., Edge S.B., Mamounas E.P., Gralow J., Goldstein L.J., Pritchard K.I., Braun S., Cobleigh M.A., Langer A.S., Perotti J., Powles T.J., Whelan T.J., and Browman G.P. J. Clin. Oncol. 20 (2002) 3317-3327
2. Bates D.J., Foster A.B., Griggs L.J., Jarman M., Leclercq G., and Devleeshouwer N. Biochem. Pharmacol. 31 (1982) 2823-2827
3. Cuzick J., Powles T., Veronesi U., Forbes J., Edwards R., Ashley S., and Boyle P. Lancet 361 (2003) 296-300
4. LHRH-Agonists in Early Breast Cancer Overview Group. Lancet 369 (2007) 1711-1723
5. Cuzick J., Forbes J., and Edwards R. Lancet 360 (2002) 817-824
6. Baum M., Buzdar A., Cuzick J., Forbes J., Houghton J., Howell A., Sahmoud T., and The ATAC (Arimidex Tamoxifen Alone or in Combination) Trialists' Group. Cancer 98 (2003) 1802-1810
7. Aebi S., and Pagani O. Drugs 67 (2007) 1393-1401
8. Gallicchio L., Lord G., Tkaczuk K., Danton M., Lewis L.M., Lim C.K., and Flaws J.A. Breast Cancer Res. Treat. 85 (2004) 89-97
9. Peyrade F., Frenay M., Etienne M.C., et al. Clin. Pharmacol. Ther. 59 (1996) 401-410
10. Rutquist L.E., Johansson H., Signomklao H., Johanssson U., Fornander T., and Wilking N. J. Natl. Cancer Inst. 87 (1995) 645-651
11. Crewe H.K., Notley L.M., Wunsch R.M., Lennard M.S., and Gillam E.M. Drug Metab. Dispos. 30 (2002) 869-874
12. Desta Z., Ward B.A., Soukhova N.V., and Flockhart D.A. J. Pharmacol. Exp. Ther. 310 (2004) 1062-1075
13. Katzenellenbogen B.S., Norman M.J., Eckert R.L., Peltz S.W., and Mangel W.F. Cancer Res. 44 (1984) 112-119
14. Young C.L., Lang L., Zeruesenay D., Qianqian Z., James M.R., David A.F., and Todd C.S. Cancer Chemother. Pharmacol. 55 (2005) 471-478
15. Veronesi U., Maisonneuve P., Costa A., Sacchini V., Maltoni C., Robertson C., Rotmensz N., and Boyle P. Lancet 352 (1998) 93-97
16. Stearns V., Johnson M.D., Rae J.M., Morocho A., Novielli A., Bhargava P., Hayes D.F., Desta Z., and Flockhart D.A. J. Natl. Cancer Inst. 95 (2003) 1758-1764
17. Murphy C., Fotsis T., Pantzar P., Adlercreutz H., and Martin F. J. Steroid Biochem. 28 (1987) 609-618
18. Lien E.A., Solheim E., Kvinnsland S., and Ueland P.M. Cancer Res. 48 (1988) 2304-2308
19. Brown R.R., Bain R., and Jordan V.C. J. Chromatogr. 272 (1983) 351-358
20. Manns J.E., Hanks S., and Brown J.E. J. Pharm. Biomed. Anal. 16 (1998) 847-852
21. Kisanga E.R., Gjerde J., Guerrieri-Gonzaga A., Pigatto F., Pesci-Feltri A., Robertson C., Serrano D., Pelosi G., Decensi A., and Lien E.A. Clin. Cancer Res. 10 (2004) 2336-2343
22. Decensi A., Robertson C., Viale G., Pigatto F., Johansson H., Kisanga E.R., Veronesi P., Torrisi R., Cazzaniga M., Mora S., Sandri M.T., Pelosi G., Luini A., Goldhirsch A., Lien E.A., and Veronesi U. J. Natl. Cancer Inst. 95 (2003) 779-790
23. Adam H.K., Douglas E.J., and Kemp J.V. Biochem. Pharmacol. 27 (1979) 145-147
24. Kemp J.V., Adam H.K., Wakeling A.E., and Slater R. Biochem. Pharmacol. 32 (1983) 2045-2052
25. Lim H.K., Stellingweif S., Sisenwine S., and Chan K.W. J. Chromatogr. A 831 (1999) 227-241
26. Sanders J.M., Burka L.T., Shelby M.D., Newbold R.R., and Cunningham M.L. J. Chromatogr. B Biomed. Sci. Appl. (1997) 181-185
27. Lu W., Poon G.K., Carmichael P.L., and Cole R.B. Anal. Chem. 68 (1996) 668-674
28. Lee K.H., Ward B.A., Desta Z., Flockhart D.A., and Jones D.R. J. Chromatogr. B 791 (2003) 245-253
29. Golander Y., and Sternson L.A. J. Chromatogr. 181 (1980) 41-49
30. Mendenhall D.W., Kobayashi H., Shih F.M., Sternson L.A., Higuchi T., and Fabian C. Clin. Chem. 24 (1978) 1518-1524